Dr. Timothy Martin Fernandes, MD

Dr. Fernandes practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Fernandes' NPI, 1669680757, was assigned on May 20, 2007. Dr. Fernandes graduated from University Of Cincinnati College Of Medicine in 2006. Dr. Fernandes holds California license A112514.

Dr. Fernandes' primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Fernandes' primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Fernandes is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fernandes practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Fernandes' primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Fernandes is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Fernandes' licenses on file in 2 states: California and Ohio.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), pneumonia, pulmonary fibrosis, pulmonary heart disease and tobacco use among the conditions Dr. Fernandes treats.

CMS data shows 476 Medicare services from Dr. Fernandes across 11 procedure codes in 2024, for 193 Medicare patients. Medicare paid $33,451 for them.

CMS counts 193 Medicare patients who saw Dr. Fernandes in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fernandes' median patient age at 63, with 58% women.

In 2024, Dr. Fernandes wrote 1,226 Medicare Part D claims for 124 patients. 35% of them were for generic drugs. CMS names the drug for 1,098 of them, across 16 drugs with 11 or more claims each, at $6,944,818 in total drug cost. In 2023, CMS named 1,003 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Fernandes for performance year 2024, reported as part of a group. Dr. Fernandes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fernandes as offering telehealth.

Dmand AI links 41 papers to Dr. Fernandes, published from 2014 to 2024. 2022 was the busiest year, with 7. The most frequent topics are Pulmonary Embolism, Hypertension, Pulmonary and Endarterectomy. Dr. Fernandes has published most often in Pulm Circ. Dr. Fernandes' most frequent co-authors are Kim Marie Kerr, MD, Demosthenes Gabriel Papamatheakis, MD and David S. Poch, MD.

Dmand AI links Dr. Fernandes to 1 clinical trial. Conditions studied include Familial Primary Pulmonary Hypertension and Pulmonary Arterial Hypertension.

CMS Open Payments shows 528 general payments to Dr. Fernandes from 11 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 68% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $222,748.

Dmand AI lists 3 awards for Dr. Fernandes, most recently Member, Academy of Clinician Scholars in 2023. Dr. Fernandes serves on Critical Care Committee.

Dr. Fernandes graduated from University Of Cincinnati College Of Medicine in 2006. Dr. Fernandes is a member of ACCP, ATS and International Society for Heart and Lung Transplantation.

Dr. Fernandes is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.